Discontinuation report TRANSDERM-NITRO 0.4
Report ID | 119964 |
Drug Identification Number | 00852384 |
Brand name | TRANSDERM-NITRO 0.4 |
Common or Proper name | Transderm Nitro 0.4 |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NITROGLYCERIN |
Strength(s) | 0.4MG |
Dosage form(s) | PATCH (EXTENDED RELEASE) |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 30 |
ATC code | C01DA |
ATC description | VASODILATORS USED IN CARDIAC DISEASES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-10-31 |
Actual discontinuation date | 2020-10-31 |
Remaining supply date | 2020-10-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | The 0,6 mg will still be available until stock depletion or shelf life expiration (Aug 2021 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-12-21 | French | Compare |
v3 | 2020-12-21 | English | Compare |
v2 | 2020-07-10 | French | Compare |
v1 | 2020-07-10 | English | Compare |
Showing 1 to 4 of 4